Informed Consent for Clinical Trials | oneAMYLOIDOSISvoice

Trusted Resources: Education

Scientific literature and patient education texts

Back to Education / Patient Education

Informed Consent for Clinical Trials

key information

source: U.S Food & Drug Administration

year: 2018

summary/abstract:

The term informed consent is mistakenly viewed as the same as getting a research participant’s signature on the consent form. FDA believes that obtaining a research participant’s verbal or written informed consent is only part of the process.

Informed Consent Involves Providing a Potential Participant With: 

• Adequate information to allow for an informed decision about participation in the clinical investigation.
• Facilitating the potential participant’s understanding of the information.
• An appropriate amount of time to ask questions and to discuss with family and friends the research protocol and whether you should participate.
• Obtaining the potential participant’s voluntary agreement to participate.
• Continuing to provide information as the clinical investigation progresses or as the subject or situation requires.


More on Clinical Trial Education:

 
read more

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close